VBI Vaccines Inc at National Securities Biotech Investor Summit (Virtual) Transcript
Hello, everyone. This is Julianna from National. And we are going to get started. Just you know, we are recording this meeting. (Operator Instructions) but I'll go ahead and turn it over to Cosme. Thank you.
± -
Welcome, everyone, and good afternoon. It is my pleasure to introduce to you Jeff Baxter, the CEO of VBI Vaccines; and Dave Anderson, the Chief Scientific Officer of the company. VBI has emerged as once the pioneers of leading companies in the vaccine space. I will allow them to introduce themselves, but before, I give a brief background on the company.
They are developing very interesting technology, breakthrough technology in the vaccine space, which is based on virus-like particles that stimulate the innate and adaptive immune responses to combat infectious diseases and cancer. It's an immunotherapy company with a very advanced product that is seeking FDA approval for vaccination against the hepatitis B virus. But today, we'll be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
